CCP, DRAP ink MoU to strengthen Pakistan’s pharma sector

The Competition Commission of Pakistan (CCP) has signed a Memorandum of Understanding (MoU) with the Drug Regulatory Authority of Pakistan (DRAP) for strengthening the regulatory and competitive landscape of Pakistan’s pharmaceutical and therapeutic goods sector. The MoU was signed between Salman Amin, Member of the Competition Commission, and Dr Ubaidullah, Chief Executive Officer of DRAP, read a statement. This MoU provides a framework for bilateral cooperation between the two institutions. “The agreement will enhance the exchange of information and data, joint enforcement, and the monitoring of misleading advertisements, unfair competition in the pharmaceutical sector, and transparent marketing claims for healthcare products and over-the-counter (OTC) categories. “The framework also includes cooperation on digital data sharing, institutional capacity building, research, and policy analysis,” read the statement.